Therapeutic Asset Ratings
1,055 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nerve Growth Factor
Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital
P2/3
CCC
(52)
NILUTAMIDE
Metastatic Prostate Carcinoma
VA Office of Research and Development
P2/3
CCC
(52)
Nuz-001
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD
P2/3
CCC
(52)
Orelabrutinib
Hematopoietic And Lymphoid System Neoplasm
Beijing InnoCare Pharma Tech Co., Ltd.
P2/3
CCC
(52)
Oxyhydrogen Nanobubble Infusion
Parkinson Disease
dr. Siti Nurlaela, SpN
P2/3
CCC
(52)
Pertuzumab
Colorectal Neoplasm
Cancer Research UK
P2/3
CCC
(52)
Pertuzumab
Ovarian Neoplasm
Cancer Research UK
P2/3
CCC
(52)
Pertuzumab
Pancreatic Neoplasm
Cancer Research UK
P2/3
CCC
(52)
Rapa-501 Autologous T Stem Cells
Amyotrophic Lateral Sclerosis
Rapa Therapeutics LLC
P2/3
CCC
(52)
Rifaximin
Cystic Fibrosis
Wake Forest University Health Sciences
P2/3
CCC
(52)
sh006
Hepatocellular Carcinoma
Nanjing Sanhome Pharmaceutical, Co., Ltd.
P2/3
CCC
(52)
Shr-8068
Non-Small Cell Lung Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P2/3
CCC
(52)
Siltuximab
B-Cell Acute Lymphoblastic Leukemia
Merck Sharp & Dohme LLC
P2/3
CCC
(52)
Sls-005 Trehalose
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD
P2/3
CCC
(52)
Sonazoid
Breast Cancer
The Netherlands Cancer Institute
P2/3
CCC
(52)
SUBA-ITRACONAZOLE COMPONENT ITRACONAZOLE
Ovarian Cancer
AstraZeneca
P2/3
CCC
(52)
TAMOXIFEN
Diffuse Large B-Cell Lymphoma
Sohag University
P2/3
CCC
(52)
Trametinib
Ovarian Neoplasm
Cancer Research UK
P2/3
CCC
(52)
Tuvonralimab
Triple-Negative Breast Carcinoma
Harbin Medical University
P2/3
CCC
(52)
Tyenne
B-Cell Acute Lymphoblastic Leukemia
Merck Sharp & Dohme LLC
P2/3
CCC
(52)
Umbralisib
Marginal Zone Lymphoma
Yazeed Sawalha
P2/3
CCC
(52)
Vidutolimod
Melanoma
National Cancer Institute (NCI)
P2/3
CCC
(52)
Oligog Dry Powder For Inhalation
Cystic Fibrosis
AlgiPharma AS
P2/3
CCC
(51)
Rimiducid
Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
P2/3
CCC
(51)
VEMURAFENIB
Colorectal Neoplasm
Cancer Research UK
P2/3
CCC
(51)
Showing 901 to 925 of 1,055 assets
Previous
Page 37 of 43
Next